Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Quantum Computing Method-for-increasing-sensitivity-to-chemically-induced-terminal-differentiation

 Data transmission system
Accordingly, the present invention has been devised with a view to substantially eliminating the ...


 Iodine gas laser device
The present invention provides an iodine laser comprising a tubular receptacle containing a gaseous ...


 Housing system for a laser
OF A PREFERRED EXAMPLE EMBODIMENT AND OF THE BEST MODE OF THE INVENTION A conventional wave-guide ...


 Cryogenic infrared laser in deuterium
In accordance with this invention, an infrared laser in deuterium is provided that lases in the 4 ....


 Method of bonding two parts together and article produced thereby
OF THE INVENTION Referring to FIG. 1, there is shown one form of an article, generally designated ...


 Semiconductor device
It is, therefore, an object of the present invention to eliminate the above-described problems. It ...


 Overdrive control of FET power amplifier
I claim: 1. In combination: a FET power amplifier including a gate electrode; an overdrive control ...


 Magnetic display panels
OF THE PREFERRED EMBODIMENTS Referring now to the drawing by numerals of reference and first to FIG...


 Method of making compensated collinear reading or writing bar arrays assembled from subunits
An object of the present invention is to provide a large array fabrication process that will permit ...


 Process for suppressing electromigration in conducting lines formed on integrated circuits by control of crystalline boundary orientation
It is an object of this invention to provide a process for suppressing electromigration in ...


 Method for increasing sensitivity to chemically induced terminal differentiation

Details
Inventors: Pontremoli, Sandro; Breslow, Ronald; Marks, Paul A.; Rifkind, Richard A.;
Assignee: Sloan-Kettering Institute for Cancer Research (New York, NY); The Trustees of Columbia University in the City of New York (New York, NY)
Primary Examiner: Waddell; Frederick E.
Assistant Examiner: Criares; T. J.
Attorney, Agent or Firm: White; John P.

The present invention provides a method of selectively inducing terminal differentiation of neoplastic cells and thereby inhibiting proliferation of such cells which comprises treating the cells so as to render them resistant to an antitumor agent and contacting the resulting resistant cells under suitable conditions with an amount of a compound effective to selectively induce terminal differentiation of such cells. The compound has a structure: [R-A ]-B-[A.sub.1 -B.sub.1 -].sub.a [A.sub.2 -B.sub.2 -].sub.b [A.sub.3 -R.sub.1 ]. The invention also concerns a method of treating a patient having a tumor characterized by proliferation of neoplastic which comprises administering to the patient an amount of an antitumor agent to render the cells resistant to the antitumor agent and subsequently administering to the patient an amount of the compound effective to selectively induce terminal differentiation of such neoplastic cells and thereby inhibit their proliferation.

DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method of selectively inducing terminal differentiation of neoplastic cells and thereby inhibiting proliferation of such cells which comprises treating the cells so as to render them resistant to an antitumor agent and contacting the resulting resistant cells under suitable conditions with an amount of a compound effective to selectively induce terminal differentiation of such cells.
The compound has a structure: [R-A]-B-[A.
sub.
1 -B.
sub.
1 -].
sub.
a [A.
sub.
2 -B.
sub.
2 -].
sub.
b [A.
sub.
3 -R.
sub.
1 ] wherein each of A, A.
sub.
1, A.
sub.
2, and A.
sub.
3 represent a polar group which comprises a nitrogen, sulfur or oxygen atom and wherein each of A, A.
sub.
1, A.
sub.
2, and A.
sub.
3 may independently be the same as, or different from, the others of A, A.
sub.
1, A.
sub.
2, and A.
sub.
3 ; wherein each of R and R.
sub.
1 is a hydrogen atom; a lower alkyl, alkenyl, or alkynyl group; or a group having the structure: ##STR2## each R.
sub.
2 and R.
sub.
3 being a hydrogen atom or a lower alkyl, alkenyl, or alkynyl group; and wherein each of R, R.
sub.
1, R.
sub.
2 and R.
sub.
3 may independently be the same as, or different from, the others of R, R.
sub.
1, R.
sub.
2, and R.
sub.
3 ; wherein each [R-A] and [A.
sub.
3 -R.
sub.
1 ] have a dipolar moment greater than about 2.
7 Debye units; wherein each of B, B.
sub.
1, and B.
sub.
2 represents a nonpolar group which comprises at least 4 atoms in a chain, the termini of which chains are attached to A and A.
sub.
1, A.
sub.
1 and A.
sub.
2, and A.
sub.
2 and A.
sub.
3 respectively; wherein each such atom is oxygen, nitrogen, carbon, or sulfur and wherein each of B, B.
sub.
1, and B.
sub.
2 may independently be the same as, or different from, the others of B, B.
sub.
1, and B.
sub.
2 ; and wherein each of a and b is independently 0 or 1.
The antitumor agent may be one of numerous chemotherapy agents such as an alkylating agent, an antimetabolite, a hormonal agent, an antibiotic, colchicine, a vinca alkaloid, L-asparaginase, procarbazine, hydroxyurea, mitotane, nitrosoureas or an imidazole carboxamide



Related patents
  Method for enhancing the safety of metal-ligand chelates as magnetic resonance imaging agents by addition of calcium ions
What is claimed is: 1. In a method for enhancing safety in the in vivo use of methal-ligand chelate complexes as magnetic resonance imaging agents comprising ...
  Hydrated biodegradable superparamagnetic metal oxides
OF THE INVENTION 1. Preparation of Coated Superparamagnetic Iron Oxide Particles The synthesis of superparamagnetic iron oxide particles for use as MRI contrast agents ...
  Halide-free process for the synthesis of ETS-10
OF THE INVENTION The present invention is directed towards crystalline titanium molecular sieve zeolites which have a pore size of approximately 8 Angstrom units and ...
  Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
OF THE INVENTION Compounds of the present invention can be made according to the schematic procedure shown or other methods using commercially available starting ...
  Macrocyclic polyamines
OF THE INVENTION Macrocyclic polyamines which form stable complexes with metal ions are known. The present invention is directed to macrocyclic polyamines in which ...
  Fishing lure retriever
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A fishing lure retriever comprising: a weighted body, ...
  Magnetic resonance imaging agents
OF THE INVENTION The complexing agents employed in this invention are derivatives of well-known polyaminocarboxylic acid chelating agents, such as DTPA and ...
  Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor
We claim: 1. A method for detecting and locating any inflammatory and/or tumor foci in a patient which comprises administering to said patient, by nebulization for ...
  Extended lifetime railgap switch
I claim: 1. In a railgap switch of the type having an elongate blade electrode made of conductive material, an elongate housing made of insulating material for ...
  Interhalogen based combustion-driven laser which provides continuous wave output lasing from dual species
Having thus described typical embodiments of my invention, that which I claim as new and desire to secure by Letters Patent of the United States is: 1. A method of ...

0.094

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved